Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.

OBJECTIVES Cervical cancer is the second most common cancer in women in developing countries, including India. Recently, microRNAs (miRNAs) are gaining importance in cancer biology because of their involvement in various cellular processes. The present study aimed to profile miRNA expression pattern in cervical cancer, identify their target genes, and understand their role in carcinogenesis. METHODS Human papillomavirus (HPV) infection statuses in samples were assessed by heminested polymerase chain reaction followed by direct DNA sequencing. Next-generation sequencing and miRNA microarray were used for miRNA profiling in cervical cancer cell lines and tissue samples, respectively. MicroRNA signature was validated by quantitative real-time PCR, and biological significance was elucidated using various in silico analyses. RESULTS Cervical cancer tissues samples were mostly infected by HPV type 16 (93%). MicroRNA profiling showed that the pattern of miRNA expression differed with respect to HPV positivity in cervical cancer cell lines. However, target and pathway analyses indicated identical involvement of these significantly deregulated miRNAs in HPV-positive cervical cancer cell lines irrespective of type of HPV infected. Microarray profiling identified a set of miRNAs that are differentially deregulated in cervical cancer tissue samples which were validated using quantitative real-time PCR. In silico analyses revealed that the signature miRNAs are mainly involved in PI3K-Akt and mTOR pathways. CONCLUSIONS The study identified that high-risk HPV induces similar carcinogenic mechanism irrespective of HPV type. The miRNA signature of cervical cancer and their target genes were also elucidated, thereby providing a better insight into the molecular mechanism underlying cervical cancer development.

[1]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[2]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[3]  Frank J. Slack,et al.  The Role of MicroRNAs in Cancer , 2006, The Yale journal of biology and medicine.

[4]  Sin Hang Lee,et al.  Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories , 2007, Infectious Agents and Cancer.

[5]  Reuven Agami,et al.  Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. , 2008, Cancer research.

[6]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[7]  Eran Halperin,et al.  miRNAkey: a software for microRNA deep sequencing analysis , 2010, Bioinform..

[8]  W. Filipowicz,et al.  The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.

[9]  R. Bhargava,et al.  MicroRNA analysis in human papillomavirus (HPV)-associated cervical neoplasia and cancer , 2010, Infectious Agents and Cancer.

[10]  Jiarui Li,et al.  MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer , 2012, International journal of molecular sciences.

[11]  K. Kaarthigeyan Cervical cancer in India and HPV vaccination , 2012, Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology.

[12]  Hong Shi,et al.  MiR-125b Inhibits Tumor Growth and Promotes Apoptosis of Cervical Cancer Cells by Targeting Phosphoinositide 3-Kinase Catalytic Subunit Delta , 2012, Cellular Physiology and Biochemistry.

[13]  F. Luo,et al.  Identification of aberrantly expressed miRNAs in rectal cancer. , 2012, Oncology reports.

[14]  B. Kaczkowski,et al.  Send Orders of Reprints at Bspsaif@emirates.net.ae a Decade of Global Mrna and Mirna Profiling of Hpv-positive Cell Lines and Clinical Specimens , 2022 .

[15]  Emmanuel Barillot,et al.  ncPRO-seq: a tool for annotation and profiling of ncRNAs in sRNA-seq data , 2012, Bioinform..

[16]  Martin Reczko,et al.  DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows , 2013, Nucleic Acids Res..

[17]  Jacques Ferlay,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .

[18]  Yingnan Sun,et al.  miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma , 2014, Molecular and Cellular Biochemistry.

[19]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[20]  Sin Hang Lee,et al.  From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice , 2014, Cancers.

[21]  Y. Huang,et al.  MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1 , 2014, British Journal of Cancer.

[22]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[23]  H. An,et al.  Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: clinical impact of miR-363-3p. , 2014, Gynecologic oncology.

[24]  C. Pérez-Plasencia,et al.  Utility of MicroRNAs and siRNAs in Cervical Carcinogenesis , 2015, BioMed research international.

[25]  H. Schayek,et al.  MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma , 2015, Molecular Cancer.

[26]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[27]  W. Hou,et al.  Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer. , 2015, International journal of clinical and experimental pathology.

[28]  G. Blandino,et al.  Oncogenic MicroRNAs: Key Players in Malignant Transformation , 2015, Cancers.

[29]  Yuanbo Li,et al.  MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway , 2016, Tumor Biology.

[30]  T. Lumley,et al.  gplots: Various R Programming Tools for Plotting Data , 2015 .

[31]  Zhe Wang,et al.  miR-136 Modulates TGF-β1-Induced Proliferation Arrest by Targeting PPP2R2A in Keratinocytes , 2015, BioMed research international.

[32]  M. Cui,et al.  Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1. , 2015, International journal of clinical and experimental pathology.

[33]  Artemis G. Hatzigeorgiou,et al.  DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..

[34]  Yun Xiao,et al.  miR-429 inhibits migration and invasion of breast cancer cells in vitro , 2014, International journal of oncology.

[35]  Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells , 2016, BMC Cancer.

[36]  Anushya Muruganujan,et al.  PANTHER version 10: expanded protein families and functions, and analysis tools , 2015, Nucleic Acids Res..

[37]  F. Nielsen,et al.  The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer , 2017, British Journal of Cancer.